Adaptimmune Therapeutics
ADAP
#9324
Rank
โ‚ฌ60.56 M
Marketcap
0,24ย โ‚ฌ
Share price
-20.31%
Change (1 day)
-81.36%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚ฌ0.22 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.22 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Adaptimmune Therapeutics - Total assets on balance sheet (from 2014 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ0.25 B-16.62%
2022-12-31โ‚ฌ0.30 B-26.04%
2021-12-31โ‚ฌ0.41 B13.04%
2020-12-31โ‚ฌ0.36 B126.33%
2019-12-31โ‚ฌ0.16 B-33.01%
2018-12-31โ‚ฌ0.24 B3.24%
2017-12-31โ‚ฌ0.23 B5.1%
2016-12-31โ‚ฌ0.22 B
2015-06-30โ‚ฌ0.26 B558.38%
2014-06-30โ‚ฌ40.68 M2823.79%
2013-06-30โ‚ฌ1.39 M-55.56%
2012-06-30โ‚ฌ3.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ1.42 B 534.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ61.58 M-72.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.50 B 126.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ2.68 B 1,098.43%๐Ÿ‡บ๐Ÿ‡ธ USA